Case Study: Dr. Rabih-Gabriel Jaouhari, R&D Director of PR euroCHEM
Fast and precise information retrieval helps chemicals manufacturers to answer client questions and win more contracts
Answering client questions at the start of a new project requires information—and when those questions concern whether you can produce a chemical and at what cost, getting to the right answers quickly is the difference between winning and losing a contract. PR euroCHEM relies on Reaxys for rapid and reliable answers.
Whether PR euroCHEM receives a request to synthesize a new chemical or a known chemical via known or more cost-effective or sustainable methods, their first step is always research. Dr. Jaouhari goes to the literature to assess the viability and efficiency of possible synthesis methods and to calculate the costs of production. It’s important for him to be able to perform quick and accurate substance and synthesis searches so that he can present the client with a quote that is fully supported with clear evidence.
"We’ve had a high level of success with Reaxys in terms of speed, precision and finding answers." Dr. Rabih-Gabriel Jaouhari, PR euroCHEM
According to Dr. Jaouhari, the greatest benefit of Reaxys is its speed. He estimates it is at least twice as fast to prepare for a new project with Reaxys as with the other solution he has used. Reaxys reduces the amount of literature he needs to read and gives him the full picture. Being able to answer client questions sooner means having a better chance of winning the contract. He believes that Reaxys has helped PR euroCHEM maintain their high level of success.
"With the previous solution, it took 4 or 5 days to produce a project plan and quotation. With Reaxys, I can do the same work in 2 days." Dr. Rabih-Gabriel Jaouhari, PR euroCHEM
Download the free case study to learn more
Elsevier R&D Solutions supporting PR euroCHEM
Enable better informed preclinical drug safety decisions with comprehensive, fully searchable FDA/EMA drug approval documents and comparative extracted drug safety data.
Learn more about PharmaPendium